The Cost-Effectiveness of Initial vs Delayed Lanreotide for Treatment of Metastatic Enteropancrea...

Peptide receptor radionuclide therapy as first-line systemic treatment in advanced inoperable/metastatic neuroendocrine tumors

S Satapathy, BR Mittal, A Sood, A Sood… - Clinical Nuclear …, 2020 - journals.lww.com
Purpose Advanced inoperable/metastatic neuroendocrine tumors (NETs) pose a therapeutic
challenge with limited treatment options. Peptide receptor radionuclide therapy (PRRT) …
被引用次数：19 相关文章 所有 6 个版本